Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. LTRN
LTRN logo

LTRN Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Lantern Pharma Inc (LTRN) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
3.590
1 Day change
2.57%
52 Week Range
5.740
Analysis Updated At
2026/05/29
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

LTRN is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has some short-term technical strength, but there is no proprietary buy signal, no recent news catalyst, no analyst upgrade momentum, and no financial data supporting a clear long-term entry. Based on the current data, I would not buy it today.

Technical Analysis

Pre-market price is 3.42, sitting below R1 at 3.642 and above the pivot at 3.141, which suggests the stock is recovering but not yet breaking out. MACD histogram is positive at 0.0838, though it is contracting, which weakens the momentum case. RSI_6 at 74.904 indicates the stock is near overbought rather than offering a clean discounted entry. Moving averages are converging, showing a neutral-to-slightly constructive trend, but not a strong trend confirmation. Overall, the chart is mildly bullish short term, but not compelling for a long-term buy.

Options Data

Bullish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio

Options sentiment is mixed. The open interest put-call ratio of 0.12 is very bullish and suggests traders are positioned more on the call side. However, the option volume put-call ratio of 1.26 shows heavier put activity today, which tempers the bullish reading. IV is extremely high at 302.9, with historical volatility also elevated at 121.59, indicating this is a highly speculative name. Overall options data points to bullish positioning but with active near-term hedging or caution.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
4
Buy
10

Positive Catalysts

  • ["Very bullish open interest put-call ratio at 0.12", "Stock trend model suggests positive forward returns over 1 week and 1 month", "Price is trading above pivot support at 3.141", "MACD histogram remains positive"]

Neutral/Negative Catalysts

  • ["No news in the recent week", "No AI Stock Picker signal today", "No SwingMax signal recently", "Insiders are neutral", "Hedge funds are neutral", "RSI is elevated near overbought territory", "No recent analyst or price-target catalyst provided", "No recent congress trading data"]

Financial Performance

No usable latest-quarter financial snapshot was provided, so there is no confirmed revenue, earnings, or growth trend to support a long-term buy decision. Because the latest quarter season is unavailable in the data, I cannot justify the stock on fundamentals here.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target trend was provided in the dataset, so there is no evidence of improving Wall Street sentiment. Based on the available information, Wall Street pros appear neutral rather than bullish: there are no upgrades, no target increases, and no clear consensus catalyst.

Wall Street analysts forecast LTRN stock price to rise
1 Analyst Rating
Wall Street analysts forecast LTRN stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 3.500
sliders
Low
25
Averages
25
High
25
Current: 3.500
sliders
Low
25
Averages
25
High
25
No data

No data

People Also Watch